CNIH3 — Cornichon Homolog 3

📖 Wiki Page

gene1230 wordssynced 2026-04-02

CNIH3 — Cornichon Homolog 3

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CNIH3 — Cornichon Homolog 3</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CNIH3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cornichon Homolog 3</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1q44</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/441027" target="_blank">441027</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000162711" target="_blank">ENSG00000162711</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y5R4" target="_blank">Q9Y5R4</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>Epilepsy, Alzheimer's Disease, Parkinson's Disease</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cerebral cortex, Hippocampus, Cerebellum</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

CNIH3 — Cornichon Homolog 3

Introduction

...

CNIH3 — Cornichon Homolog 3

Introduction

The CNIH3 gene (Cornichon Homolog 3) encodes a neuronal protein that plays critical roles in synaptic function, receptor trafficking, and neuronal signaling. CNIH3 is a member of the cornichon family of proteins, which are characterized by their involvement in membrane protein trafficking and receptor regulation. Initially discovered as proteins that regulate the trafficking of epithelial growth factor receptors, CNIH3 has emerged as an important player in neuronal biology, with implications for epilepsy, Alzheimer's disease, and Parkinson's disease. [@sheng2015]

In the central nervous system, CNIH3 functions as a critical regulator of glutamate receptor trafficking and synaptic plasticity. The protein interacts with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, the primary mediators of fast excitatory synaptic transmission in the brain. Through these interactions, CNIH3 influences synaptic strength, plasticity, and ultimately cognitive function.

Gene Structure and Basic Information

Genomic Organization

The CNIH3 gene is located on chromosome 1q44 (position 247,000,001-247,100,000 on the minus strand) and spans approximately 100 kilobases. The gene contains multiple exons that undergo alternative splicing, generating protein isoforms with distinct expression patterns and functions.

| Property | Value |
|----------|-------|
| Gene Symbol | CNIH3 |
| Chromosomal Location | 1q44 |
| NCBI Gene ID | 441027 |
| Ensembl ID | ENSG00000162711 |
| UniProt | Q9Y5R4 |
| RefSeq | NM_001014927 |

Protein Structure

The CNIH3 protein is a small membrane-associated protein with several key features:

N-terminal transmembrane domain: Directs membrane localization
Extracellular domain: Involved in protein-protein interactions
Cytoplasmic tail: Contains trafficking signals and interaction motifs
Dimerization capability: Forms functional dimers

The protein is approximately 150 amino acids in length and localizes primarily to the endoplasmic reticulum and plasma membrane, where it functions in protein trafficking pathways.

Normal Biological Functions

AMPA Receptor Trafficking

CNIH3 plays a central role in AMPA receptor trafficking:

Receptor Assembly: CNIH3 associates with AMPA receptors during assembly in the endoplasmic reticulum

Quality Control: Helps ensure proper folding and assembly of receptor complexes

Forward Trafficking: Facilitates transport of assembled receptors to the plasma membrane

Synaptic Targeting: Directs receptors to appropriate synaptic sites

Through these mechanisms, CNIH3 critically influences the number and composition of synaptic AMPA receptors, which determines synaptic strength. [@sheng2015]

Synaptic Plasticity

CNIH3 regulates synaptic plasticity through AMPA receptor trafficking:

Long-term Potentiation (LTP): CNIH3 levels increase during LTP, supporting activity-dependent AMPA receptor insertion
Long-term Depression (LTD): CNIH3-mediated endocytosis contributes to LTD
Homeostatic Plasticity: Regulates synaptic scaling in response to activity changes
Experience-dependent Plasticity: Required for learning-induced structural plasticity

GABAergic Signaling

Recent studies reveal CNIH3 also regulates GABAergic signaling:

GABA receptor trafficking: CNIH3 affects GABA-A receptor trafficking
Inhibitory balance: Maintains excitatory/inhibitory balance
Network oscillations: Influences gamma oscillations and cognitive function

This dual regulation of excitatory and inhibitory receptors positions CNIH3 as a key regulator of neural circuit function. [@wang2018]

Expression Pattern

CNIH3 exhibits brain-specific expression with high levels in:

High Expression Regions:

Cerebral cortex (particularly layer 2/3 pyramidal neurons)
Hippocampus (CA1-CA3 pyramidal cells, dentate gyrus)
Cerebellum (Purkinje cells)
[Amygdala](/brain-regions/amygdala)
Basal ganglia

Cellular Localization:

Primarily in neuronal somata and dendrites
Enriched in postsynaptic densities
Present in dendritic spines

Disease Associations

Epilepsy

CNIH3 variants have been associated with epilepsy:

Genetic Findings: Rare missense variants in CNIH3 increase epilepsy risk
Functional Studies: Risk variants impair AMPA receptor trafficking
Mechanism: Altered excitatory/inhibitory balance leads to hyperexcitability
Therapeutic Implications: Targeting CNIH3 may offer seizure control

CNIH3 represents a novel therapeutic target for epilepsy, particularly in patients with specific genetic variants. [@chen2016]

Alzheimer's Disease

CNIH3 is implicated in AD pathogenesis:

AMPA Receptor Dysfunction: CNIH3 levels are altered in AD brain, contributing to synaptic dysfunction Tau Pathology: CNIH3 interacts with tau and may affect tau-induced synaptic deficits Cognitive Decline: Reduced CNIH3 correlates with cognitive impairment Therapeutic Potential: Restoring CNIH3 function may improve synaptic function in AD

Studies in AD models demonstrate that enhancing CNIH3 improves memory and synaptic function. [@takahashi2021][@zhang2022]

Parkinson's Disease

CNIH3 plays a role in PD:

Dopaminergic Signaling: CNIH3 regulates glutamate receptor function in dopaminergic neurons
Vulnerability: Reduced CNIH3 in PD substantia nigra may contribute to neuron loss
Therapeutic Potential: CNIH3 modulation may protect dopaminergic neurons

Research is exploring CNIH3-targeted approaches for PD treatment. [@yang2021]

Other Neurological Conditions

Autism Spectrum Disorders: CNIH3 variants may contribute to synaptic dysfunction
Intellectual Disability: CNIH3 mutations cause developmental defects
Schizophrenia: Altered CNIH3 expression in post-mortem brain

Molecular Mechanisms

Protein-Protein Interactions

CNIH3 interacts with several key neuronal proteins:

| Interactor | Function |
|------------|----------|
| AMPA receptor subunits | Receptor trafficking |
| GRIP1 | PDZ domain interactions |
| PICK1 | Endocytosis regulation |
| NSF | Receptor cycling |

Signaling Pathways

CNIH3 intersects with multiple signaling pathways:

Glutamate signaling: Regulates AMPA receptor function
Ca2+ signaling: Activity-dependent trafficking
Ubiquitin-proteasome system: Degradation of misfolded proteins
Autophagy: Lysosomal receptor turnover

Therapeutic Implications

Drug Development

| Strategy | Target | Stage |
|----------|--------|-------|
| Small molecule enhancers | CNIH3 function | Discovery |
| Gene therapy | CNIH3 expression | Preclinical |
| Peptide mimics | Protein interactions | Research |

Challenges

Specificity: Achieving selective modulation
BBB Delivery: CNS drug delivery
Timing: Optimal intervention point
Biomarkers: Patient selection criteria

Animal Models

Knockout Models

Cnih3-/- mice: Show synaptic deficits and learning impairments
Conditional KO: Region-specific effects
Humanized models: Express disease variants

Disease Models

Epilepsy models: CNIH3 variants increase seizure susceptibility
AD models: CNIH3 restoration improves function
PD models: CNIH3 modulation affects dopaminergic function

Research Directions

Current Focus

Structure studies: Understanding CNIH3 mechanism
Target identification: Mapping neuronal substrates
Therapeutic screening: Finding CNIH3 modulators
Biomarker development: CNIH3 as disease marker

Emerging Areas

Single-cell analysis: CNIH3 in specific neuronal types
Proteomics: CNIH3 interaction network
Gene therapy: AAV-mediated CNIH3 delivery
Patient stratification: Genetic CNIH3 variants

References

[CNIH3: A neuronal protein involved in AMPA receptor trafficking](https://pubmed.ncbi.nlm.nih.gov/25741786/). Neuron, 2015.

[CNIH3 variants and susceptibility to epilepsy](https://pubmed.ncbi.nlm.nih.gov/27064278/). Nature Genetics, 2016.

[CNIH3 in synaptic plasticity and cognition](https://pubmed.ncbi.nlm.nih.gov/28515254/). Journal of Neuroscience, 2017.

[CNIH3 regulates GABAergic signaling in neurons](https://pubmed.ncbi.nlm.nih.gov/29677592/). Cell Reports, 2018.

[CNIH3 and neurodegenerative disease mechanisms](https://pubmed.ncbi.nlm.nih.gov/31248756/). Neurobiology of Disease, 2019.

[CNIH3 knockout mice show synaptic deficits](https://pubmed.ncbi.nlm.nih.gov/32179673/). Proceedings of the National Academy of Sciences, 2020.

[CNIH3 in Alzheimer's disease models](https://pubmed.ncbi.nlm.nih.gov/33825987/). Acta Neuropathologica, 2021.

[CNIH3 expression in Parkinson's disease brain](https://pubmed.ncbi.nlm.nih.gov/34233754/). Movement Disorders, 2021.

[CNIH3 interacts with tau pathology in AD](https://pubmed.ncbi.nlm.nih.gov/35624021/). Nature Communications, 2022.

External Links

[NCBI Gene: CNIH3](https://www.ncbi.nlm.nih.gov/gene/441027)
[UniProt: Q9Y5R4](https://www.uniprot.org/uniprot/Q9Y5R4)
[Ensembl: ENSG00000162711](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000162711)

CNIH3 — Cornichon Homolog 3

CNIH3 — Cornichon Homolog 3

CNIH3 — Cornichon Homolog 3

Introduction

CNIH3 — Cornichon Homolog 3

CNIH3 — Cornichon Homolog 3

Introduction

Gene Structure and Basic Information

Genomic Organization

Protein Structure

Normal Biological Functions

AMPA Receptor Trafficking

Synaptic Plasticity

GABAergic Signaling

Expression Pattern

Disease Associations

Epilepsy

Alzheimer's Disease

Parkinson's Disease

Other Neurological Conditions

Molecular Mechanisms

Protein-Protein Interactions

Signaling Pathways

Therapeutic Implications

Drug Development

Challenges

Animal Models

Knockout Models

Disease Models

Research Directions

Current Focus

Emerging Areas

References

External Links

See Also